2017 Duke-UNC Symposium on Viral Oncology and AIDS Malignancy
Register now for the Duke-UNC Symposium on Viral Oncology and AIDS Malignancy.
Registration is free but required for planning purposes. Please register by December 1.
Date: Thursday, December 14, 2017
Time: 9:00 am – 3:00 pm (Continental breakfast at 8:30)
Location: Great Hall at the Trent Semans Center, Duke University School of Medicine (Venue and Parking)
Speakers:
Lau
rie Krug, PhD, Associate Professor
Department of Molecular Genetics and Microbiology
Stony Brook University
“Herpesviruses Armed to Combat Uracils: The Role of dUTPase and Uracil-DNA Repair in Gammaherpesvirus Pathogenesis and Genomic Stability”
Dirk Dittmer, PhD, Professor, Department of Microbiology and Immunology
Teamlead, programs in Virology and Global Oncology
UNC Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill
“MTOR Inhibition in Kaposi Sarcoma and Viral Lymphoma”
Jeffrey Cohen, MD, Chief, Laboratory of Infectious Diseases
Chief, Medical Virology Section
National Institute of Allergy and Infectious Diseases
“EBV-Associated Immunodeficiencies and Vaccination to Prevent EBV-Associated Disease”
Symposium Schedule |
|
| 8:30 – 9:00 a.m. | Continental Breakfast and Poster Setup |
| 9:00 – 9:10 a.m. | Welcome & Introduction |
| 9:10 – 10:05 a.m. | Laurie Krug, PhD, Associate Professor of Molecular Genetics and Microbiology, Stony Brook University “Herpesviruses Armed to Combat Uracils: The Role of dUTPase and Uracil-DNA Repair in Gammaherpesvirus Pathogenesis and Genomic Stability” |
| 10:05 a.m. | Introduction |
| 10:10 – 11:05 a.m. | Dirk Dittmer, PhD, Professor of Microbiology and Immunology, University of North Carolina, Chapel Hill “MTOR Inhibition in Kaposi Sarcoma and Viral Lymphoma” |
| 11:05 – 11:25 a.m. | Coffee Break |
| 11:25 a.m. | Introduction |
| 11:30 – 12:25 a.m. | Jeffrey Cohen, MD, Chief, Laboratory of Infectious Diseases and Medical Virology Section, National Institute of Allergy and Infectious Diseases “EBV-Associated Immunodeficiencies and Vaccination to Prevent EBV-Associated Disease” |
| 12:25 p.m. | Closing Remarks |
| 12:30 – 1:30 p.m. | Lunch (Vegetarian and gluten-free options will be available.) |
| 1:30 – 3:00 p.m. | Poster Session |
| 2:45 p.m. | Awards for best posters |
Don’t forget to register here. For more information, please contact Christy Krupa (christine.krupa@duke.edu), 919-684-3031.
Please consider presenting a poster even if your work is not specifically related to viral oncology. We would like to encourage poster presentation by scientists and trainees broadly in the fields of virology and oncology. Our hope is to bring together scientists in these two disciplines to cross-pollinate ideas and seed collaboration. Final results are not required, and ‘works in progress’ and posters that have been recently presented at other meetings are welcome. Prizes for the best posters will be given at 2:45 pm.
We gratefully acknowledge the following sponsors:
Duke Center for Virology; Duke Center for AIDS Research; Duke Cancer Institute; UNC Lineberger Comprehensive Cancer Center; and UNC Center for AIDS Research
